Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite
Phase 2
Withdrawn
- Conditions
- COVID-19Acute Respiratory Distress SyndromeAcute Respiratory Failure
- Interventions
- Drug: Normal Saline
- First Posted Date
- 2020-05-26
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Hope Pharmaceuticals
- Registration Number
- NCT04401527
- Locations
- ๐บ๐ธ
Participating Research Facility, Fort Worth, Texas, United States
Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate
Terminated
- Conditions
- Calciphylaxis
- First Posted Date
- 2017-10-24
- Last Posted Date
- 2018-11-20
- Lead Sponsor
- Hope Pharmaceuticals
- Target Recruit Count
- 5
- Registration Number
- NCT03319914
- Locations
- ๐บ๐ธ
Massachusetts General Hospital, Boston, Massachusetts, United States
๐บ๐ธCleveland Clinic, Cleveland, Ohio, United States
๐บ๐ธVeterans Administration Medical Center, Albany, New York, United States
A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients
Phase 3
Terminated
- Conditions
- Calciphylaxis
- Interventions
- Drug: Placebo-Normal Saline
- First Posted Date
- 2017-05-12
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- Hope Pharmaceuticals
- Target Recruit Count
- 29
- Registration Number
- NCT03150420
- Locations
- ๐จ๐ฆ
Kingston Health Sciences Centre, Kingston, Ontario, Canada
๐บ๐ธMassachusetts General Hospital, Boston, Massachusetts, United States
๐ฌ๐งSalford Royal Hospital NHS Foundation Trust, Salford, Manchester, United Kingdom
Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage
- First Posted Date
- 2014-06-27
- Last Posted Date
- 2018-03-30
- Lead Sponsor
- Hope Pharmaceuticals
- Target Recruit Count
- 6
- Registration Number
- NCT02176837
- Locations
- ๐บ๐ธ
University of Virginia Medical Center, Charlottesville, Virginia, United States
Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm
- First Posted Date
- 2009-04-01
- Last Posted Date
- 2020-05-21
- Lead Sponsor
- Hope Pharmaceuticals
- Target Recruit Count
- 19
- Registration Number
- NCT00873015
- Locations
- ๐บ๐ธ
University of Virginia Health System Medical Center, Charlottesville, Virginia, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath